Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene ExpressionDavid A. Jacobsohn, Michael A. Pulsipher, Kimberly A. Kasow et al.|Transplantation and Cellular Therapy|2018Cited by 44
Liver Transplantation Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Atypical Mevalonic AciduriaSonali Chaudhury, P F Whitington, E. Alonso et al.|American Journal of Transplantation|2012Cited by 43
Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantationChristine Duncan, K. Scott Baker, Ruta Brazauskas et al.|Bone Marrow Transplantation|2018Cited by 42
Age-dependent pharmacokinetic profile of single daily dose i.v. busulfan in children undergoing reduced-intensity conditioning stem cell transplantWilliam Tse, Morris Kletzel, R. Duerst et al.|Bone Marrow Transplantation|2009Cited by 34
Identification of Adenoviruses in Specimens from High-Risk Pediatric Stem Cell Transplant Recipients and ControlsXiaotian Zheng, Ben Z. Katz, Judith A. Guzman‐Cottrill et al.|Journal of Clinical Microbiology|2007Cited by 23